Advanced Glycation End Products
Alison H. Goldin, Joshua A. Beckman, Ann Marie Schmidt et al. · Circulation · 2006
Advanced glycation end products (AGEs) are proteins or lipids that become glycated after exposure to sugars. AGEs are prevalent in the diabetic vasculature and contribute to the development of atherosclerosis. The presence and accumulation of AGEs in many different cell types affect extracellular and intracellular structure and function. AGEs contribute to a variety of microvascular and macrovascular complications through the formation of cross-links between molecules in the basement membrane of the extracellular matrix and by engaging the receptor for advanced glycation end products (RAGE). Activation of RAGE by AGEs causes upregulation of the transcription factor nuclear factor-kappaB and its target genes. Soluble AGEs activate monocytes, and AGEs in the basement membrane inhibit monocyte migration. AGE-bound RAGE increases endothelial permeability to macromolecules. AGEs block nitric oxide activity in the endothelium and cause the production of reactive oxygen species. Because of the emerging evidence about the adverse effects of AGEs on the vasculature of patients with diabetes, a number of different therapies to inhibit AGEs are under investigation.
Cited by 2,256 works. doi:10.1161/circulationaha.106.621854
Authors
References
- A General Mechanism for Vitamin B 6 -catalyzed Reactions 1
- Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
- Structure Elucidation of a Senescence Cross-Link from Human Extracellular Matrix
- Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.
- Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
- RAGE Mediates a Novel Proinflammatory Axis
- PROTEIN PRENYLATION: Molecular Mechanisms and Functional Consequences
- Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.
- Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
- Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface.